Alpharma Inc.
News from Alpharma Inc. highlights the most recent developments
Published in Lab Law Weekly, July 6th, 2007
This trend article is an immediate alert from NewsRx to identify the most recent news developments at Alpharma Inc..
Report 1: Alpharma Inc. (NYSE:ALO), a leading global specialty pharmaceutical company through its Pharmaceuticals Division, this week presented positive results of a pharmacokinetic study of its investigational abuse-deterrent, extended-release opioid at the 26th annual scientific meeting of the American Pain Society in Washington, D.C. The data demonstrated the release characteristics of this extended-release morphine sulfate plus sequestered naltrexone product were...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Lab Law Weekly
Source: Lab Law Weekly (2007-07-06)
More Articles from Lab Law Weekly
- A.P. Pharma, Inc.
A.P. Pharma Closes $40 Million Common Stock Offering; Underwriters Exercise Full over-Allotment Option - AARP
Leading New York Physician Calls on Legislature to Pass Rx Gift Disclosure Legislation - AARP
Senior Advocates Join to Say 'No Way' to 'No-Growth' Budget - Acusphere, Inc.
Acusphere Announces Closing of Common Stock and Warrant Offering - Alcoholism Risk Factors
Findings from RAND Corporation broaden understanding of alcoholism risk factors - Alliance of Specialty Medicine
Nation's Medical Specialists Applaud House Action to Establish Clear and Valid Approach to Physician Reporting on Quality Measures - More from this issue of Lab Law Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
